Recruiting Dry Eye Studies in Shelby
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye....
A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.
The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if ...
About Dry Eye Clinical Trials in Shelby
Dry eye disease is a common condition that occurs when tears are unable to provide adequate lubrication for the eyes. It affects millions of people and can cause discomfort and vision problems. Treatment includes artificial tears, prescription eye drops, and procedures to conserve tears.
There are currently 2 dry eye clinical trials recruiting participants in Shelby, NORTH%20CAROLINA. These studies are seeking a combined 232 participants. Research is being sponsored by Vanda Pharmaceuticals, BioTissue Holdings, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dry Eye Clinical Trials in Shelby — FAQ
Are there dry eye clinical trials in Shelby?
Yes, there are 2 dry eye clinical trials currently recruiting in Shelby, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Shelby?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Shelby research site will contact you about next steps.
Are clinical trials in Shelby free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Shelby studies also compensate for your time and travel.
What dry eye treatments are being tested?
The 2 active trials in Shelby are testing new therapies including novel drugs, biologics, and treatment approaches for dry eye.
Data updated March 2, 2026 from ClinicalTrials.gov